Seres Therapeutics, Inc. (MCRB) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
8/25
Growth 2
Margin 1
Expansion 3
Platform 1
Financial 1
latest quarter score
Earnings Reports
- 8
- 6
- 10
- 10